SCHEMBL7800422

SCHEMBL7800422

COc1cc2nc(N)nc(-c3ccccc3Cl)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.57
HSP90AA1 P07900 3/20 0.50
HSP90AB1 P08238 3/20 0.50
DHFR P00374 1/20 0.49
TP53 P04637 2/20 0.48
MAPT P10636 1/20 0.48
KLK7 P49862 1/20 0.48
KLK14 Q9P0G3 1/20 0.48
KLK5 Q9Y337 1/20 0.48
THRB P10828 1/20 0.47
WHR1 P49842 1/20 0.47
EGFR P00533 1/20 0.44
NTSR1 P30989 1/20 0.43
ADORA1 P30542 2/20 0.43
ACHE P22303 1/20 0.43
NSD2 O96028 1/20 0.43
ATM Q13315 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799233 0.85 ADORA2A (0.62) ADORA2AHSP90AA1HSP90AB1DHFRMAPT
SCHEMBL7791033 0.84 ADORA2A (0.61) ADORA2AHSP90AA1HSP90AB1DHFRTP53
SCHEMBL7790971 0.84 ADORA2A (0.57) ADORA2AHSP90AA1HSP90AB1DHFRWHR1
SCHEMBL7791023 0.84 ADORA2A (0.57) ADORA2AHSP90AA1HSP90AB1DHFRKLK7
SCHEMBL7585771 0.84 ADORA2A (0.57) ADORA2AHSP90AA1HSP90AB1DHFRTP53
SCHEMBL7799250 0.81 ADORA2A (0.53) ADORA2AHSP90AA1HSP90AB1DHFRWHR1
SCHEMBL1257435 0.80 WHR1 (0.71) ADORA2ADHFRWHR1EGFRADORA1
SCHEMBL30759714 0.80 WHR1 (0.71) ADORA2ADHFRWHR1EGFRADORA1
SCHEMBL7800398 0.80 ADORA2A (0.55) ADORA2ADHFRTP53MAPTKLK7
SCHEMBL7799239 0.79 ADORA2A (0.51) ADORA2AHSP90AA1HSP90AB1DHFRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed